dina1957
Wed, Feb-28-07, 12:20
http://www.diabetesincontrol.com/images/logo.gif
Accumulation of Cholesterol Linked With Type 2 Diabetes
Date: Tuesday, February 27 ~ 13:11:08 CST
Topic: DIC Newsletter Issue 353
An international team of scientists have discovered a possible link between accumulation of cholesterol –lipid toxicity and type 2 diabetes.
Type 2 diabetes is defined by two things. One is insulin resistance, and the other is reduced insulin production. The second is caused by reduction in insulin release by "beta cells" in the pancreas. Why this happens is poorly understood; however, it has been suggested that the build up of toxic lipids in the cells could be a reason.
Using mice, scientists showed that pancreatic beta cells, responsible for insulin release, begin to malfunction when their cholesterol levels build up.
They examined the role of a molecular transporter called "ATP-binding cassette transporter A1" (ABCA1). ABCA1 is important for "cholesterol homeostasis" which regulates cholesterol levels in cells. It also affects insulin secretion in pancreatic beta cells. The scientists used genetically engineered mice and switched off their ABCA1 genes.
They found that these mice had normal insulin sensitivity, but lower levels of insulin secretion and significantly impaired glucose tolerance, displaying one of the classic symptoms of type 2 diabetes. They effectively became diabetic.
When they examined the pancreas of the mice, isolated and tested the cells "in vitro", they found the cholesterol homeostasis was different to normal as was the secretion of insulin. They also found a significant accumulation of cholesterol in the beta cells.
Cholesterol plays a number of roles in the human body, and one of these is to keep cell membranes healthy so they allow the right chemicals to pass in and out of the cells. However, the levels of cholesterol have to be regulated precisely. n the case of the beta cells, if the cholesterol levels accumulate, they interfere with the secretion of insulin. This is the one of the possible explanations, say the scientists on this study.
However, there are competing theories. One is that amylin, one of the peptide hormones produced by the beta cells and secreted at the same time as insulin, builds up and interferes with insulin release. According to Dr Michael Hayden, in whose lab the study was conducted, more studies will be done this year to see if cholesterol regulation problems also occur in humans with type 2 diabetes.
"Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment." Liam R Brunham, Janine K Kruit, Terry D Pape, Jenelle M Timmins, Anne Q Reuwer, Zainisha Vasanji, Brad J Marsh, Brian Rodrigues, James D Johnson, John S Parks, C Bruce Verchere and Michael R Hayden Nature Medicine Published online: 18 February 2007 doi:10.1038/nm1546
Click here for Abstract. (http://www.nature.com/nm/journal/vaop/ncurrent/abs/nm1546.html) ===========================
Learn about the ONlY Instant Disposable In Office A1c Test: Studies have shown that by providing the A1c test in the office while the patient is present, can lower A1c by a full point. Learn about the only 99% accurate disposable A1c test that is CLIA waived and cost less then 10 dollars and reimbursed at least 21 dollars. http://www.a1ctest.com (http://www.a1ctest.com/)
===========================
Help us keep this newsletter free—update your profile
http://www.diabetesincontrol.com/recommend.php
This article comes from Diabetes In Control
http://www.diabetesincontrol.com (http://www.diabetesincontrol.com/)
The URL for this story is:
http://www.diabetesincontrol.com/modules.php?name=News&file=article&sid=4582
Accumulation of Cholesterol Linked With Type 2 Diabetes
Date: Tuesday, February 27 ~ 13:11:08 CST
Topic: DIC Newsletter Issue 353
An international team of scientists have discovered a possible link between accumulation of cholesterol –lipid toxicity and type 2 diabetes.
Type 2 diabetes is defined by two things. One is insulin resistance, and the other is reduced insulin production. The second is caused by reduction in insulin release by "beta cells" in the pancreas. Why this happens is poorly understood; however, it has been suggested that the build up of toxic lipids in the cells could be a reason.
Using mice, scientists showed that pancreatic beta cells, responsible for insulin release, begin to malfunction when their cholesterol levels build up.
They examined the role of a molecular transporter called "ATP-binding cassette transporter A1" (ABCA1). ABCA1 is important for "cholesterol homeostasis" which regulates cholesterol levels in cells. It also affects insulin secretion in pancreatic beta cells. The scientists used genetically engineered mice and switched off their ABCA1 genes.
They found that these mice had normal insulin sensitivity, but lower levels of insulin secretion and significantly impaired glucose tolerance, displaying one of the classic symptoms of type 2 diabetes. They effectively became diabetic.
When they examined the pancreas of the mice, isolated and tested the cells "in vitro", they found the cholesterol homeostasis was different to normal as was the secretion of insulin. They also found a significant accumulation of cholesterol in the beta cells.
Cholesterol plays a number of roles in the human body, and one of these is to keep cell membranes healthy so they allow the right chemicals to pass in and out of the cells. However, the levels of cholesterol have to be regulated precisely. n the case of the beta cells, if the cholesterol levels accumulate, they interfere with the secretion of insulin. This is the one of the possible explanations, say the scientists on this study.
However, there are competing theories. One is that amylin, one of the peptide hormones produced by the beta cells and secreted at the same time as insulin, builds up and interferes with insulin release. According to Dr Michael Hayden, in whose lab the study was conducted, more studies will be done this year to see if cholesterol regulation problems also occur in humans with type 2 diabetes.
"Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment." Liam R Brunham, Janine K Kruit, Terry D Pape, Jenelle M Timmins, Anne Q Reuwer, Zainisha Vasanji, Brad J Marsh, Brian Rodrigues, James D Johnson, John S Parks, C Bruce Verchere and Michael R Hayden Nature Medicine Published online: 18 February 2007 doi:10.1038/nm1546
Click here for Abstract. (http://www.nature.com/nm/journal/vaop/ncurrent/abs/nm1546.html) ===========================
Learn about the ONlY Instant Disposable In Office A1c Test: Studies have shown that by providing the A1c test in the office while the patient is present, can lower A1c by a full point. Learn about the only 99% accurate disposable A1c test that is CLIA waived and cost less then 10 dollars and reimbursed at least 21 dollars. http://www.a1ctest.com (http://www.a1ctest.com/)
===========================
Help us keep this newsletter free—update your profile
http://www.diabetesincontrol.com/recommend.php
This article comes from Diabetes In Control
http://www.diabetesincontrol.com (http://www.diabetesincontrol.com/)
The URL for this story is:
http://www.diabetesincontrol.com/modules.php?name=News&file=article&sid=4582